Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver
about
Human conditions of insulin-like growth factor-I (IGF-I) deficiencyMecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEXPotentiating the efficacy of molecular targeted therapy for hepatocellular carcinoma by inhibiting the insulin-like growth factor pathwayThe gene encoding rat insulinlike growth factor-binding protein 1 is rapidly and highly induced in regenerating liverA low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans.IGF-1 modulates gene expression of proteins involved in inflammation, cytoskeleton, and liver architecture.Age-related insulin resistance: is it an obligatory finding? The lesson from healthy centenarians.Advancing age and insulin resistance: new facts about an ancient history.Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humansInsulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humansThe IGF axis and hepatocarcinogenesis.Targeting insulin-like growth factor axis in hepatocellular carcinoma.Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults.Insulin-like growth factor-I for the treatment of type 1 diabetes.The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets.Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans.Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion.Glucose utilization in a patient with hepatoma and hypoglycemia. Assessment by a positron emission tomographyEvidence of a role for insulin-like growth factor binding protein (IGFBP)-3 in metabolic regulation.Human GH receptor-IGF-1 receptor interaction: implications for GH signaling.Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin.Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury.An obligatory requirement for the heterotrimeric G protein Gi3 in the antiautophagic action of insulin in the liver.Effect of insulin-like growth factor-1 on the responses to and recognition of hypoglycemia in humans. A comparison with insulin.Resistance to multikinase inhibitor actions mediated by insulin like growth factor-1Insulinlike growth factors in human malignancy.miR-223 Deficiency Protects against Fas-Induced Hepatocyte Apoptosis and Liver Injury through Targeting Insulin-Like Growth Factor 1 ReceptorGlypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathwayEmerging role of insulin-like growth factor-binding protein 7 in hepatocellular carcinoma.Role of IGF-1 in glucose regulation and cardiovascular disease.Regulation of rat hepatic low density lipoprotein receptors. In vivo stimulation by growth hormone is not mediated by insulin-like growth factor I.Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors.The role of liver-derived insulin-like growth factor-I.Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivinThe Association Between IGF-1 Levels and the Histologic Severity of Nonalcoholic Fatty Liver DiseaseRelationship between serum circulating insulin-like growth factor-1 and liver fat in the United StatesIsoflurane anesthesia induces liver injury by regulating the expression of insulin-like growth factor 1.Insulin-like growth factor II in hepatocellular carcinoma.Insulin-like growth factor-I (IGF-I) misuse in athletes and potential methods for detection.The effect of forced expression of mutated K-RAS gene on gastrointestinal cancer cell lines and the IGF-1R targeting therapy.
P2860
Q26822806-9611D2FA-35D0-4DDE-B91C-52692A32D234Q28273812-83BFFA93-FCF7-4CE5-8533-32CC368146F8Q28534009-71F91240-BA85-457C-844E-666582BADA19Q28582561-629CB1CC-F160-46C7-810A-87E2551C6E78Q30449290-04E4A55D-8003-4E67-8519-17C9E240AC24Q30846570-6F1F4ADB-13F3-40F9-9AC9-F4039E4CFD49Q32164773-3C5E87C3-C492-40D5-B147-33EF112BBEDAQ33723742-66285418-1949-4BBC-BD58-37710B703D82Q33905407-D454C24B-B506-4DEF-9A88-8CE61767B452Q33907536-E22A4342-6E0D-4DE2-9393-768BE01CBA0BQ33918694-4BD35CBE-7B30-494B-9992-03E8259D3AB8Q33951057-B228D2F6-86E7-474D-8F1F-5804DACFE677Q34132745-E270F2D9-E155-4EB6-9475-F36A2714DA5EQ34166740-33E3AF57-E772-449F-82E0-F3E98FC70470Q34182483-AF755EB2-0E97-4772-97CC-5C27E2482123Q34184378-59B2DDD6-B853-4BBD-8DAC-A5B4D12C86C6Q34220852-E656103F-710A-4A7F-B0E2-8A4F8E7F8C67Q34221209-DA3DDB51-07B8-416D-87DB-3C98F4F440F1Q34392615-19370159-9D43-4486-99C7-4CDF4B895252Q34422481-6E43AF43-2CCF-4DE1-8133-E5A52F5B8F6CQ34573364-20BEF67A-1906-4435-8535-2F9B76D7EAE3Q35597135-FEFC1385-07F6-43CC-B64D-CD85C56D511AQ35669855-AFE2ADC5-9986-4BA6-95AA-A207B6BCE6E8Q35823863-1D2AB892-4102-4903-9AB9-0A820DD7520CQ36019476-766A71E9-74AE-4A50-B25D-6CB5F792FBA4Q36418856-D02ED6D2-6104-4FC6-995D-B34F76D08761Q36509113-DE69EAE0-22CB-4E86-ABEA-D470B64E42C3Q36818088-6E24A277-E4A0-4F19-ADE5-1A8032303E1FQ37031704-84AA96A3-E732-4743-9B46-DEBB34EE2688Q37269401-84FC815A-F329-4431-9FAD-0C873660CD05Q37350108-7FA7215E-C6C0-4005-8E68-105010CDF1CCQ37367772-316D7D22-F374-4C99-AC52-74DEFA0CD3A5Q37381848-64BDE664-22CF-438D-B9C4-CD9FCDC7A642Q37438760-B15FF614-E04D-42B5-8577-97578DCEE983Q37620363-56DB3E31-0F5E-4B6D-82E8-C451EEDA80A6Q37695553-FEF11CE6-2A91-43A0-A28F-7ED71B413DC7Q37735041-3397ED89-9ED6-4F20-BF6D-E5EDC882DF54Q37755101-C49FECEE-508D-497E-8386-4642444F8AF8Q38128225-BFA102E8-9C72-433A-B702-18330292F35AQ38764039-2B9919DF-D531-4327-BEF2-3B897EEE46FE
P2860
Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Insulin-like growth factor I b ...... enerating, and fetal rat liver
@ast
Insulin-like growth factor I b ...... enerating, and fetal rat liver
@en
type
label
Insulin-like growth factor I b ...... enerating, and fetal rat liver
@ast
Insulin-like growth factor I b ...... enerating, and fetal rat liver
@en
prefLabel
Insulin-like growth factor I b ...... enerating, and fetal rat liver
@ast
Insulin-like growth factor I b ...... enerating, and fetal rat liver
@en
P2093
P2860
P356
P1476
Insulin-like growth factor I b ...... enerating, and fetal rat liver
@en
P2093
P2860
P304
P356
10.1172/JCI113451
P407
P577
1988-04-01T00:00:00Z